01 / STACK OVERVIEW
What Is The Wolverine Stack?
The Wolverine Stack is the most powerful peptide combination for accelerated healing and tissue regeneration. Named for its near-superhuman recovery profile — BPC-157 and TB-500 attack tissue repair from two completely different mechanisms, creating a synergistic effect that neither compound achieves alone. Used by elite athletes, post-surgical patients, and anyone with chronic injuries that conventional medicine can't resolve.
BPC-157
10mg vial · 33.3 mcg/unit
LOCAL REPAIR AGENT
Body Protection Compound — 15 amino acid peptide isolated from gastric juice. Activates growth factor receptors (VEGFR2, FGFR) at injury sites. Accelerates angiogenesis (new blood vessel formation), tendon-to-bone attachment, ligament healing, and gut repair. Works locally at the injury site — inject near damaged tissue for maximum effect.
TB-500
10mg vial · 33.3 mcg/unit
SYSTEMIC REPAIR AGENT
Synthetic fragment of Thymosin Beta-4. Binds actin — the protein in all cells that drives cellular motility and structural repair. Reduces systemic inflammation via NF-κB pathway inhibition. Promotes stem cell migration to injury sites throughout the entire body. Works systemically — one injection repairs everywhere.
02 / SYNERGY MECHANISM
Why These Two Together
L
BPC-157 — LOCAL PRECISION
Concentrates repair signals at the specific injury site. Accelerates local angiogenesis (blood flow to damaged tissue), stimulates local growth factor cascades, and drives tendon/ligament fibroblast proliferation. Think of it as calling the repair crew directly to the worksite.
S
TB-500 — SYSTEMIC AMPLIFICATION
Floods the body with stem cells, reduces systemic inflammation, and upregulates actin availability in every cell. Creates the optimal systemic environment for the local BPC-157 repair process to work. Think of it as clearing traffic, reducing friction, and bringing reinforcements everywhere.
2×
COMBINED EFFECT
Animal studies show the combination heals tendon injuries significantly faster than either peptide alone. BPC-157 drives local tissue architecture reconstruction while TB-500 provides the cellular building blocks and removes inflammatory barriers. The result: the fastest non-surgical tissue repair protocol in peptide research.
Injury Protocol: For acute injuries — BPC-157 injected subcutaneously as close to the injury site as possible. TB-500 injected into any SC site (systemic distribution). Run both simultaneously for maximum effect.
03 / RECONSTITUTION
Vial Preparation
BPC-157 — 10mg VIAL
10mg + 3.0 mL BAC water
33.3 mcg per unit
250mcg: 7.5 units / 0.075 mL
500mcg: 15 units / 0.15 mL
750mcg: 22.5 units / 0.225 mL
TB-500 — 10mg VIAL
10mg + 3.0 mL BAC water
33.3 mcg per unit
500mcg: 15 units / 0.15 mL
1mg: 30 units / 0.30 mL
2mg: 60 units / 0.60 mL
Storage: Both vials: lyophilized powder stable at room temp 6 months. After reconstitution: refrigerate (2–8°C), use within 28–30 days. Protect from light. Do NOT freeze reconstituted vials.
04 / DOSING PROTOCOL
Stack Dose Ranges
BPC-157
| LEVEL | DOSE | FREQUENCY | INJECTION SITE |
|---|
| LOW |
250mcg / day |
Daily |
SC near injury site or abdominal fat pad |
| STANDARD |
500mcg / day |
Daily |
SC near injury (preferred) or any SC site |
| HIGH |
750mcg / day |
Daily |
Can split AM/PM — 375mcg × 2 |
TB-500
| LEVEL | DOSE | FREQUENCY | NOTES |
|---|
| LOADING |
2–4mg / week |
2× weekly (Weeks 1–4) |
Front-load for acute injury or first cycle |
| MAINTENANCE |
2mg / week |
1–2× weekly (Weeks 5+) |
Standard maintenance. Split 1mg × 2 injections. |
| HIGH |
4mg / week |
2× weekly |
Severe injury or rapid recovery protocol |
05 / INJECTION SCHEDULE
Weekly Protocol
PEPTIDE
MON / THU
DAILY (TUE–SUN)
SITE
BPC-157
✓ 500mcg
✓ 500mcg daily
Near injury / abdomen
TB-500
✓ 1–2mg each
— rest days
Any SC site, rotate
Timing: BPC-157 — no fasting required. Can inject any time. Best results when injected as close to the injury site as possible. TB-500 — no fasting required. Injected 2× weekly regardless of BPC-157 timing.
Acute Injury Protocol (Weeks 1–2): TB-500 loading dose 2mg every 3–4 days + BPC-157 750mcg daily split AM/PM. Front-loading accelerates the inflammatory-to-regenerative phase transition.
06 / BIOMARKER MONITORING
Recommended Lab Panel
INFLAMMATION — PRIMARY RECOVERY MARKERS
| MARKER | CLINICAL RANGE | OPTIMAL TARGET | NOTES |
|---|
| hs-CRPhigh-sensitivity C-reactive protein |
CLINICAL<3.0 mg/L |
OPTIMAL<0.5 mg/L |
Primary inflammation marker — should drop significantly within 4–6 weeks of stack use |
| IL-6interleukin-6 |
CLINICAL<7 pg/mL |
OPTIMAL<2 pg/mL |
Pro-inflammatory cytokine — TB-500 NF-κB inhibition drives this down |
| ESRerythrocyte sedimentation rate |
CLINICAL0–20 mm/hr |
OPTIMAL<10 mm/hr |
Secondary inflammation marker — tracks alongside CRP for recovery trajectory |
TISSUE REPAIR MARKERS
| MARKER | METHOD | NOTES |
|---|
| Ultrasound / MRIradiographic assessment |
Pre/post cycle imaging |
Tendon, ligament, muscle imaging — before and after 8–12 week cycle. Objective tissue healing confirmation. |
| VEGFvascular endothelial growth factor |
Serum — optional |
BPC-157 drives VEGF upregulation (angiogenesis). Elevated VEGF confirms mechanism is active. |
| Collagen Cross-linksCTX / P1NP |
Serum — optional |
P1NP indicates new collagen synthesis (repair). CTX indicates breakdown. Improving P1NP:CTX ratio = net tissue building. |
SAFETY PANEL
| MARKER | CLINICAL RANGE | NOTES |
|---|
| CBCcomplete blood count |
CLINICALStandard |
Baseline and at 8 weeks. Both peptides have excellent safety profile — monitoring confirms tolerability. |
| CMPcomprehensive metabolic panel |
CLINICALStandard |
Liver and kidney function. BPC-157 has hepatoprotective properties — expect normal or improved values. |
07 / CYCLE PROTOCOL
Administration Schedule
ACUTE INJURY PHASE (Wks 1–4)
TB-500: 2–4mg loading 2×/week. BPC-157: 500–750mcg daily. Aggressive front-load to drive rapid phase transition from inflammation to repair.
MAINTENANCE PHASE (Wks 5–12)
TB-500: 2mg 1–2×/week. BPC-157: 250–500mcg daily. Sustain repair environment while tissue remodeling completes.
OFF PERIOD
4–8 weeks between cycles for healthy individuals. For ongoing injury management, some practitioners run BPC-157 indefinitely at low maintenance dose (250mcg/day).
UPGRADE: KLOW STACK
Add KPV 10mg + GHK-Cu 50mg to this stack → full KLOW protocol. Adds gut/mucosal repair (KPV), skin/collagen matrix (GHK-Cu), and deeper anti-inflammatory coverage.
REQUIRES
2 vials (BPC-157 + TB-500) · BAC water · Apex V3 Pen · Refrigeration post-reconstitution
⚠ Research reference only. BPC-157 and TB-500 are not FDA-approved for human therapeutic use. Information sourced from published clinical and preclinical literature. Consult a qualified medical provider before use.